We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$9.7B
AUM Growth
-$152M
Cap. Flow
+$293M
Cap. Flow %
3.03%
Top 10 Hldgs %
29.73%
Holding
234
New
14
Increased
60
Reduced
64
Closed
43

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$74.9M
2
ABT icon
Abbott
ABT
+$45.9M
3
MOH icon
Molina Healthcare
MOH
+$43.5M
4
DHR icon
Danaher
DHR
+$42M
5
MDT icon
Medtronic
MDT
+$38M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$63.1M
2
BAX icon
Baxter International
BAX
+$38.1M
3
CNC icon
Centene
CNC
+$36.2M
4
HOLX
Hologic
HOLX
+$21.4M
5
DXCM icon
DexCom
DXCM
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 97.85%
2 Technology 0.8%
3 Industrials 0.75%
4 Communication Services 0.02%
5 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCCC icon
151
C4 Therapeutics
CCCC
$376M
$1.52M 0.02%
47,200
– –
NVAX icon
152
Novavax
NVAX
$1.23B
$1.49M 0.02%
10,400
-5,600
-35% -$962K
IDYA icon
153
IDEAYA Biosciences
IDYA
$3.41B
$1.11M 0.01%
+47,000
New +$1.09M
SLN
154
Silence Therapeutics
SLN
$521M
$1.09M 0.01%
+46,666
New +$1.08M
KOS icon
155
Kosmos Energy
KOS
$1.56B
$1.01M 0.01%
292,000
– –
KRYS icon
156
Krystal Biotech
KRYS
$9.88B
$979K 0.01%
+14,000
New +$815K
CLLS
157
Cellectis
CLLS
$286M
$670K 0.01%
82,500
– –
MCK icon
158
McKesson
MCK
$98.5B
$586K 0.01%
2,359
-71
-3% -$15.6K
LYV icon
159
Live Nation Entertainment
LYV
$41.2B
$563K 0.01%
4,700
– –
RDY icon
160
Dr. Reddy's Laboratories
RDY
$9.82B
$556K 0.01%
42,500
– –
EL icon
161
Estee Lauder
EL
$29B
$499K 0.01%
1,348
– –
ENTG icon
162
Entegris
ENTG
$19.7B
$416K ﹤0.01%
3,000
– –
MKL icon
163
Markel Group
MKL
$25B
$370K ﹤0.01%
300
– –
OPT
164
DELISTED
Opthea Limited American Depositary Shares
OPT
$368K ﹤0.01%
49,000
– –
CYBR
165
DELISTED
CyberArk
CYBR
$364K ﹤0.01%
2,100
– –
GGG icon
166
Graco
GGG
$12.9B
$363K ﹤0.01%
4,500
– –
NYT icon
167
New York Times
NYT
$11.6B
$362K ﹤0.01%
7,500
– –
DLB icon
168
Dolby
DLB
$4.72B
$343K ﹤0.01%
3,600
– –
SWKS icon
169
Skyworks Solutions
SWKS
$9.06B
$326K ﹤0.01%
2,100
– –
EA icon
170
Electronic Arts
EA
$52.4B
$299K ﹤0.01%
2,270
– –
FTNT icon
171
Fortinet
FTNT
$112B
$289K ﹤0.01%
4,015
-6,985
-64% -$460K
AZPN
172
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$285K ﹤0.01%
1,874
-526
-22% -$80K
MKTX icon
173
MarketAxess Holdings
MKTX
$4.15B
$272K ﹤0.01%
662
– –
SPOT icon
174
Spotify
SPOT
$99.2B
$257K ﹤0.01%
1,100
– –
JD icon
175
JD.com
JD
$40.8B
$252K ﹤0.01%
3,600
– –
5 6
7
8 9

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bellevue Group's Q4 2021 Portfolio in Review

As of Q4 2021, Bellevue Group held 234 positions worth $9.7B, down 1.5% from $9.85B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bellevue Group deployed $293M of net new capital in Q4 2021, opening 14 new positions and adding to 60 existing holdings. Its largest new stake was AstraZeneca: 29,500 shares worth $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Baxter International, an estimated $38.1M trimmed.

  • Bellevue Group's largest Q4 2021 buy was AstraZeneca: 29,500 shares worth $3.44M.
  • Bellevue Group added most to CareDx in Q4 2021, an estimated $74.9M increase.
  • Bellevue Group's biggest Q4 2021 reduction was Baxter International, cutting an estimated $38.1M.
  • Bellevue Group fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $63.1M.
  • Bellevue Group's ten largest holdings make up 30% of its $9.7B portfolio in Q4 2021.
  • Bellevue Group opened 14 new positions and closed 43 in Q4 2021.
  • Bellevue Group's portfolio value fell 1.5% quarter-over-quarter to $9.7B.

Based on Bellevue Group's 13F filing for Q4 2021, filed 10 Feb 2022.